GradedCalls Analysts
Loading the ledger…
Public news sources, graded against Yahoo Finance adjusted closes (adjusted for splits and dividends) through 16 Oct 2026. Not investment advice.
GradedCallsGradedCallsGradedCalls Analysts
Loading the ledger…
NYSE · Healthcare
Pfizer · Pharmaceuticals. Historical grades below use the calls in this ledger. The list is each analyst’s latest recommendation. The bar under it is the direction for grading, not a live street tally.
Direction for grading, from the latest active call of each analyst. Strong Buy, Buy, Overweight, and Outperform count as Buy. Hold, Neutral, and Equal-Weight count as Hold. Underperform, Underweight, and Sell count as Sell. The recommendation on the call — Target raise, Upgrade to Buy, Reiterate Overweight — is a separate label.
Overall factor · 2W
36.7/100Average of active call grades
GC score4/10GC 1→GC 10
GC 1–4. Under 40 is WEAK on the GC Scale.
The overall factor is the average of the 0–100 grades on active calls at this horizon. A call superseded by a later note on the same ticker within 90 days stays visible and does not enter this average, the GC score, or the hit rate. How this is computed
Active graded
| Analyst | Firm | N | Hit | Overall factor/100 · GC 1–10 |
|---|---|---|---|---|
| Geoff Meacham | Citi | 1 | 100% | 80.7/1009/10 |
| Vamil Divan | Guggenheim | 1 | 100% | 70/1008/10 |
| Jason Gerberry | BofA | 2 | 0% | 19.6/100 |
History only. A later call on the same ticker within 90 days replaced these. The notes stay. They do not enter the overall factor.
| Date | Analyst | Recommendation | Directionfor grading | Target | Then | After | Return | Grade |
|---|---|---|---|---|---|---|---|---|
| Oct 1, 2026 Nullified Nullified — superseded by later call on Oct 8, 2026 (within 90 days). Later call | Akash TewariJefferies | Target raise Desk rating stays Buy | Buy | $29.44 | +4.7% | Hit Not scored | ||
6
In this factor
Superseded
3
Visible, not scored
Hit rate
33%
Active calls only
If followed
+4.9%
Active directional calls
Active calls on PFE were a full hit 33% of the time. Hit rate is not the rank.
| Michael Yee | UBS | 1 | 0% | 19.2/1002/10 |
| Rajesh Kumar | HSBC | 1 | 0% | 11.2/1002/10 |
Nullified — superseded by later call on Oct 8, 2026 (within 90 days). Later call
| Chris SchottJPMorgan |
| Maintain Neutral Desk rating stays Neutral |
| Hold |
| $28.00 |
| -0.6% |
| Hit Not scored |
| Jul 6, 2026 Nullified Nullified — superseded by later call on Sep 10, 2026 (within 90 days). Later call | Rajesh KumarHSBC | Downgrade to Hold Desk rating Buy → Hold | Hold | $24.32 | +4.3% | Miss Not scored |